Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
12.4M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4.28M
-
Shares change
-
+3.54M
-
Total reported value, excl. options
-
$97.1M
-
Value change
-
+$81.9M
-
Number of buys
-
14
-
Number of sells
-
-10
-
Price
-
$22.71
Significant Holders of Forte Biosciences, Inc. - COMMON STOCK (FBRX) as of Q4 2024
32 filings reported holding FBRX - Forte Biosciences, Inc. - COMMON STOCK as of Q4 2024.
Forte Biosciences, Inc. - COMMON STOCK (FBRX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.28M shares
of 12.4M outstanding shares and own 34.38% of the company stock.
Largest 10 shareholders include FRED ALGER MANAGEMENT, LLC (1.13M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (620K shares), Ikarian Capital, LLC (609K shares), ORBIMED ADVISORS LLC (600K shares), BVF INC/IL (594K shares), Cable Car Capital, LP (220K shares), Woodline Partners LP (204K shares), PERCEPTIVE ADVISORS LLC (95.7K shares), BOOTHBAY FUND MANAGEMENT, LLC (89.2K shares), and FARALLON CAPITAL MANAGEMENT LLC (35K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.